A

American Society of Health-System Pharmacists

Professional association advocating pharmacists; accredits programs

Vice President, Business Development and Strategy

Full-TimeDeadline 10/2/27
$280k - $330k/yr
Expert
Bachelor's, Master's, MBA, PharmD
Bethesda, MD, USA
HybridCandidates must live in the Washington, DC area. Starting March 2027, employees must work in the office Tuesday through Thursday.
Sales & Account ManagementBusiness Development & Partnerships
No H1B Sponsorship

About the job

Requirements
  • Demonstrated success identifying and launching new business ventures, strategic partnerships, products, services, or revenue streams that achieve measurable growth objectives.
  • Experience conducting market analysis, competitive assessment, business case development, and strategic planning in a complex healthcare, nonprofit, association, or related setting.
  • Demonstrated experience with significant financial management responsibilities, including budget development, financial forecasting, business case analysis, pricing strategies, revenue growth initiatives, and P&L accountability for substantial organizational portfolios.
  • Demonstrated success leading complex, cross-functional organizational change initiatives involving multiple business units, stakeholders, operational processes, financial considerations, and strategic objectives.
  • A bachelor's degree is required.
  • At least 10 years of senior leadership experience in business development, enterprise or B2B sales, revenue growth, or strategic partnerships within a relevant healthcare-related business, such as a hospital or health system, pharmaceutical or life sciences company, drug information and clinical data provider, health IT company, healthcare publisher, pharmacy services or distribution business, or healthcare or professional association.
  • A proven record of achieving or exceeding revenue targets and driving organizational growth.
  • Experience negotiating complex contracts, licensing, and partnership agreements.
  • Experience building and leading sales, business development, or partnership teams.
  • Budget and P&L responsibility.
  • Experience working with C-suite executives and senior decision-makers.
  • Demonstrated success developing and executing growth strategies, including new market development.
  • Exceptional interpersonal, communication, and executive presence skills.
  • Executive relationship management and ability to serve as a trusted partner to C-suite and senior decision-makers.
  • Ability to partner across business units and with key external stakeholders.
  • Team leadership and management skills.
  • Strategy execution with a results orientation.
  • Advanced financial acumen.
  • Creativity, innovation, and change management skills are required.
  • Deep understanding of healthcare and association market dynamics, customer needs, competitive environments, and emerging industry trends, and ability to translate insights into actionable business strategies and growth opportunities.
  • Ability to lead large-scale change initiatives involving strategic planning, culture change, operational execution, stakeholder alignment, and measurable business results.
  • Ability to think strategically about long-term growth opportunities while engaging in operational details to execute plans, solve problems, and achieve measurable results.
  • Experience in enterprise sales and data licensing.
  • Experience in business development and strategic partnerships.
  • Experience in revenue generation, contract negotiation, and deal structuring.
  • Experience in corporate relations.
  • Experience in pricing and business models.
  • Experience in budget development and P&L management.
  • Experience in market expansion and new market development.
  • Experience in channel partnerships and sponsorship development.
  • Experience with Salesforce, business analytics, and prospecting tools.
  • Experience with AI tools such as Claude and Copilot.
Responsibilities
  • Lead the strategy and execution of ASHP's revenue growth, including enterprise partnerships, B2B sales and marketing, data licensing, sponsorships, and product and service launch and expansion, with direct accountability for achieving revenue targets.
  • Identify, develop, and maintain relationships with executives and senior decision-makers across hospital and health-system pharmacy, pharmaceutical and medication-related industries, IT and technology companies, publishers and distributors, colleges and schools of pharmacy, professional organizations, and government entities who purchase or influence the purchase of ASHP products, services, databases, and membership.
  • Build, lead, and develop high-performing sales, business development, and partnership teams that interface with current and prospective ASHP customers and business partners.
  • Own budget development and P&L management for assigned revenue portfolios, including pricing strategy and business models for products, services, databases, and membership, and direct short- and long-term sales strategies and plans aligned with organizational financial goals.
  • Partner across ASHP business units and with internal pharmacist and clinical subject-matter experts to ensure product and service offerings are clinically credible, market-relevant, and aligned with ASHP's mission.
  • Develop and execute enterprise growth strategies that expand ASHP's influence, impact, and revenue through new business opportunities, strategic investments, and innovative partnership models.
  • Monitor healthcare, pharmacy, technology, education, and association marketplace trends; evaluate competitive dynamics, customer needs, and emerging opportunities to inform organizational strategy, product development, and investment decisions.
  • Collaborate with leaders across education, membership, pharmacy practice, publications, technology, and operations to identify, develop, launch, and scale innovative products, services, and solutions that create member and stakeholder value and generate sustainable revenue.
  • Develop member- and customer-focused value propositions and business solutions addressing the evolving needs of pharmacists, pharmacy technicians, health systems, industry partners, educators, students, and other key stakeholders.
  • Develop business cases, growth strategies, and performance reports for presentation to executive leadership.
  • Evaluate emerging technologies, business models, market trends, and partnership opportunities to create new value for ASHP and its members.
  • Lead institutional sales and licensing of ASHP drug databases, data products, and career resources across institutional and industry markets domestically and internationally.
  • Lead corporate relations and contracting with pharmaceutical, medication-related, publishing and distribution, and IT and technology industries to support business alignment and ASHP revenue generation.
  • Develop and manage strategic alliances with professional organizations and U.S. and international government entities.
  • Lead negotiation of complex contracts, licensing arrangements, and partnership agreements, including deal structuring and pricing terms.
  • Design, grow, and manage sponsorship programs and channel partnerships.
  • Identify and develop new markets, influence new product and service development, and expand the reach of existing ASHP products and services.
  • Serve as a key liaison to hospitals and health systems to determine product and service needs and provide customized packages covering ASHP products, services, and membership offerings.
  • Develop revenue and expense budgets, pricing models, and forecasts; maintain accountability for achieving business development and sales targets and report performance to executive leadership.
  • Champion the use of Salesforce, business analytics, AI, and prospecting tools to build pipeline, forecast accurately, and inform commercial decisions.
  • Represent ASHP internally and externally.
  • Travel to meet with key customers, hospital and health-system pharmacy leaders, and business partners.
  • Perform other duties as assigned.
Desired Qualifications
  • Experience evaluating and launching new business ventures, strategic investments, partnerships, acquisitions, or innovative business models.
  • A pharmacy degree (PharmD or BS Pharm) is strongly preferred.
  • A graduate degree (MBA or MS) is preferred.
  • Completion of an ASHP-accredited residency is a plus.
  • Pharmacy practice or pharmacy leadership experience, such as in a hospital or health system, is strongly preferred.
  • Healthcare or professional association experience, including involvement in state or national pharmacy associations, is preferred.

About the company

A

American Society of Health-System Pharmacists

View
Website

ASHP is the largest professional association for pharmacists and pharmacy technicians in the United States, uniting 65,000+ members across hospital, ambulatory, and health-system settings to support practice, education, and advocacy for members and patients. It accredits pharmacy residency and technician training programs and provides resources, continuing education, guidelines, and career development for professionals. It differentiates itself by combining membership services, program accreditation, and a broad public-awareness and resource hub under one umbrella. Its goal is to improve pharmacy practice and patient safety by supporting professionals, ensuring high-quality training, and delivering public education across all career stages.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Bethesda, Maryland

Founded

N/A

Get referred to American Society of Health-System Pharmacists

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Calabrese became CEO May 1, 2026, bringing accreditation depth and health-system credibility.
  • ASHP won a three-year, $3 million FDA grant to fight shortages.
  • Pakistan's ASHP-accredited residency programs expanded to Peshawar, proving international demand for its standards.

What critics are saying

  • Albert et al. v. ASHP was dismissed August 12, 2026, but antitrust claims can revive.
  • 340B fights with HRSA and manufacturers can alienate hospitals if reimbursement rules tighten.
  • If matching or accreditation faces court limits, ASHP loses core authority and member relevance.

What makes American Society of Health-System Pharmacists unique

  • ASHP accredits 3,000+ residencies and 250 technician programs under Sam Calabrese.
  • Its drug-shortage reporting and FDA-funded sourcing work make it a national pharmacy infrastructure node.
  • ASHP shapes residency standards, matching, and policy for 65,000 members across health systems.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Conference Attendance Budget
  • Professional Development Budget

Company News

ASHP
Aug 6th, 2026
Tryon elected next president of ASHP.

Tryon elected next president of ASHP. Published: August 6, 2026 Lemke, Miller Elected to Board of Directors Jennifer E. Tryon, PharmD, MS, FASHP, was elected as ASHP's new president-elect, and Todd D. Lemke, PharmD, CPEL, DPLA, FASHP, and Katherine (Kat) A. Miller, PharmD, MHA, CPEL, DPLA, FASHP, FKCHP, were elected to serve on the ASHP Board of Directors. Tryon is the senior vice president and chief pharmacy officer at Henry Ford Health in Detroit, Michigan. She recently completed a term on the ASHP Board of Directors and previously held leadership roles as the chair of the Section of Pharmacy Practice Leaders and the Council on Pharmacy Management. She is faculty for the ASHP Foundation's Pharmacy Leadership Academy and has served on section advisory groups and the ASHP House of Delegates. She is a past president of the Oregon Society of Health-System Pharmacists and has held other elected leadership roles in pharmacy associations. Tryon was the 2021 recipient of the ASHP Section of Pharmacy Practice Leaders Distinguished Service Award. Lemke is the regional director of pharmacy services at CentraCare in St. Cloud, Minnesota. His ASHP service includes terms as chair and vice chair of the Section of Inpatient Care Practitioners (SICP), SICP Advisory Group on Small and Rural Hospitals, and the Council on Pharmacy Practice. He has served on the SICP Committee on Nominations, two ASHP advisory committees, as a student mentor, residency preceptor, poster judge, and a regular contributor to Midyear Clinical Meeting & Exhibition programming, podcast episodes, and virtual roundtables. Lemke is a fellow of ASHP and has received his Certified Pharmacy Executive Leader SM designation. Miller is senior director for acute care pharmacy and clinical nutrition and residency programs executive at the University of Kansas Health System in Kansas City. Her ASHP service includes terms as chair of the Section of Pharmacy Practice Leaders, the Council on Pharmacy Management, the ASHP Section of Pharmacy Practice Managers Advisory Group on Innovation Management, and the New Practitioners Forum Advisory Group on Leadership and Career Development. She is a graduate and faculty member for the ASHP Foundation Pharmacy Leadership Academy and has contributed to multiple ASHP and ASHP Foundation advisory committees and workgroups. She is a fellow of ASHP and has received her Certified Pharmacy Executive Leader SM designation. Miller is a past president of the Kansas Council of Health-System Pharmacy (KCHP) and was designated as a fellow of KCHP. She has served as a Kansas delegate to the ASHP House of Delegates and on ASHP-affiliate boards in Kansas, Illinois, and Minnesota. Tryon will begin her term immediately. Lemke and Miller will start their three-year terms in June 2027. ASHP thanks the members of the Board of Canvassers for certifying the election results. The members are Mary Binghay, Chris Ellison, and John Spain (chair). Posted August 6, 2026

ASHP
May 19th, 2026
ASHP accreditation strengthens clinical pharmacy training in Pakistan.

ASHP accreditation strengthens clinical pharmacy training in Pakistan. Karen Blum Published: May 19, 2026 For years, Pakistan did not have a structured residency pathway for pharmacists to develop the skills needed for specialized hospital and clinical pharmacy practice. But that changed in 2020, thanks to a team of pharmacists who helped Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore become the first hospital in Pakistan to achieve ASHP accreditation for its residency program. "This was a major milestone for us, not only as an institutional achievement but also as part of our responsibility to advance pharmacy practice in Pakistan," said Omar Akhlaq Bhutta, the hospital's director of pharmacy. Today, the hospital operates first-year residency programs in Lahore and Peshawar, and a second-year residency program in Lahore. The majority of its 24 graduates have continued working for the medical center, with the rest taking posts in Saudi Arabia, the United Kingdom, and the United States. The ASHP News Center spoke with Bhutta; Saba Mazhar, residency program director and member of ASHP's International Accreditation Committee; and Adeel Siddiqui, preceptor and assistant manager of pharmacy to learn more. Why was it important for your hospital to start a pharmacy residency program? Bhutta: Training opportunities for pharmacists were mostly unstandardized; only a few institutions were working toward advanced pharmacy practices aligned with international standards. Our hospital has always believed in strengthening the pharmacy profession and creating meaningful learning opportunities for pharmacists. We had an internal residency-style training program with rotations in ambulatory care, aseptic services, inpatient care, and clinical pharmacy, but we recognized that if we wanted to truly advance clinical pharmacy in Pakistan, we needed a stronger, more structured system. When ASHP introduced the international pharmacy practice residency pathway (IPPRP), we moved forward with accreditation immediately. How did you start your program? Mazhar: We initiated the pharmacy residency program in 2014. At that stage, our focus was on ensuring that core learning experiences were incorporated, particularly those essential for pharmacists working in oncology practice settings. We began with a small cohort of four trainees and a limited scope. However, there was strong enthusiasm and commitment behind the initiative. Despite its modest beginnings, the program played an important role in shifting the mindset of the pharmacy profession locally and demonstrated the value of structured clinical training. How did ASHP help you develop and expand the program? Bhutta: ASHP played a significant role in helping us develop and expand our program. Their standards helped us build a competency-based residency model focused on clinical excellence, leadership, and patient-centered care. We had the privilege of working closely with respected ASHP leaders such as Lynnae Mahaney, Paul Bush, and David Warner, whose guidance and collaboration were invaluable. Their participation in our conferences and symposiums further strengthened our journey. This initiative also encouraged other leading institutions in the area, including Shifa International Hospital and Aga Khan University Hospital, to develop similar structured training platforms and pursue accreditation. Today, several organizations are moving in the same direction, which will continue to strengthen pharmacy practice and improve patient care across the country. How did you grow the program over time? Mazhar: We first strengthened the Lahore site by expanding learning experiences, adding more preceptors, and enhancing clinical exposure. Once the program was well-established, we expanded to our Peshawar site and successfully launched the IPPRP there, extending the same quality of structured residency training to another campus. We later introduced the International Advanced Pharmacy Practice Residency Program (IAPPRP), a second year of postgraduate training, becoming the first hospital in the region to offer this advanced level of training. We enroll two pharmacy graduates each year in IPPRP and one in IAPPRP. Five are currently enrolled across Lahore and Peshawar. Our success created momentum nationally. Shifa and Aga Khan hospitals started ASHP-accredited IPPRP programs. We started a residency networking symposium with participation from almost all major hospitals in Pakistan. Tell us more about IAPPRP. Mazhar: From the beginning, our vision was not limited to one year of residency alone. We remained in close contact with the ASHP team and discussed the need for an advanced pathway. As soon as ASHP launched the advanced program in 2022, we immediately started working on implementation. The focus of IAPPRP is to develop leadership skills in second-year residents, enabling them to practice more independently, take on advanced clinical responsibilities, and contribute at a higher level to patient care and pharmacy services. We look forward to achieving full accreditation following an ASHP audit. What are you most proud of regarding these programs and your trainees? Siddiqui: Our residents are gaining visibility globally; their research in quality improvement is getting published in well-reputed journals and their work is recognized and winning awards. We developed a team of board- and ASHP-certified preceptors who are training residents. This program has significantly elevated the level of the pharmacy profession in the country, helping to advance clinical practice standards and professional development. It creates a new hope for pharmacists in Pakistan. Posted May 19, 2026

ASHP
Apr 23rd, 2026
ASHP launches fda-funded initiative to strengthen access to drugs in short supply.

ASHP launches fda-funded initiative to strengthen access to drugs in short supply. Published: April 23, 2026 ASHP has begun the first phase of a multiyear effort to help outsourcing facilities respond more quickly when patients risk losing access to critical medications due to shortages. As part of the project, ASHP will convene a multidisciplinary, multi-specialty committee to develop a priority list of medications most vulnerable to shortages. ASHP is naming a dozen clinicians and supply chain experts to the committee, including pharmacists from multiple specialties, which will establish a matrix score that prioritizes medications based on supply chain vulnerability and clinical need. ASHP received a $3 million grant from the Food and Drug Administration (FDA) to undertake the work. "This idea of getting multiple specialties together to talk through how to prioritize these drugs is something that could broadly apply to other government initiatives," said Michael Ganio, ASHP's senior director of pharmacy practice and quality. Those initiatives include building a reserve of strategic active pharmaceutical ingredients and investing in domestic manufacturing. As part of the project's second phase, ASHP will identify medications from the prioritized list that are suitable for compounding by 503B outsourcing facilities. A second expert panel will issue requests for proposals and award funding to facilities that proactively research formulations to compound these medications. ASHP will maintain a public library of formulations available to 503B outsourcing facilities interested in compounding drugs that eventually go into shortage. "This effort isn't just about chasing supply," said Brian Cohen, ASHP's director of pharmacy supply chain resilience. "It is about identifying the most vulnerable medications, weighing their clinical importance, and being thoughtful about what can be safely compounded during shortages." Hospitals and clinics use 503B outsourcing facilities to ensure a more reliable supply of compounded and ready-to-administer drugs. Under law, the facilities can also compound copies of commercially available drugs that are on the FDA drug shortages list. But only about 20% of outsourcing facilities' total production is comprised of drugs in shortage, according to the FDA. Significant challenges - from high costs to research demands - limit their ability to respond to shortages effectively. Facilities often need six months to a year to bring products to market - and by then, the medication may have come off the FDA shortages list. Meanwhile, patients face delays in their care. "Our goal is to cut that time substantially," said Ganio. The project will also include an review of prioritized drugs to determine whether there is a risk of counterfeit activity during a period of shortage. For more than two decades, ASHP has actively monitored drug shortages, developed strategies to help members minimize the effects of shortages on pharmacy operations and patient care, and urged policymakers to adopt solutions. ASHP, which publishes quarterly national drug shortages reports, will continue to keep members informed about the progress of the new FDA-funded project. Posted April 23, 2026

ASHP
Mar 19th, 2026
ASHP names Samuel Calabrese as executive vice president and CEO.

ASHP names Samuel Calabrese as executive vice president and CEO. Published: March 19, 2026 The ASHP Board of Directors today announced the appointment of Samuel V. Calabrese, BSPharm, MBA, FASHP, CPEL, as executive vice president and CEO, effective May 1, 2026. Calabrese will become ASHP's fifth CEO in its 84-year history, succeeding longtime CEO Paul W. Abramowitz, PharmD, ScD (Hon), FASHP, who retired earlier this year. Calabrese brings decades of health-system pharmacy leadership, deep experience in pharmacy training accreditation, and a longstanding commitment to ASHP's mission and the profession. He currently serves as vice president of the ASHP Office of Accreditation Services, overseeing the accreditation processes for more than 3,000 pharmacy residency programs and 250 technician training programs nationwide. Before joining ASHP, Calabrese spent 25 years in the Cleveland Clinic Health System, holding senior leadership roles, including executive chief pharmacy officer, associate chief pharmacy officer and pharmacy administrator, director of inpatient pharmacy services, and pharmacy manager. He also served as residency program director for the Cleveland Clinic's health-system pharmacy administration and leadership residency. "We are thrilled to welcome Sam Calabrese as ASHP's CEO," said ASHP President Melanie Dodd, PharmD, PhC, BCPS, FASHP. "Sam is an exceptional leader. His deep experience in hospital and health-system pharmacy, commitment to supporting our pharmacy workforce, and unwavering dedication to ASHP's mission uniquely position him to lead the organization and guide ASHP into its next chapter of growth and impact on advancing the pharmacy profession and patient care." "I am honored to become ASHP's CEO at this pivotal time for the pharmacy workforce and patient care," Calabrese said. "ASHP has profoundly shaped my career and the profession and I am so grateful for the opportunity to serve our 65,000 members in this new capacity as we advance our shared mission and shape pharmacy's future." Calabrese has an extensive record of service to ASHP and the profession, including roles on ASHP's Board of Directors, the Commission on Affiliate Relations, the Council of Pharmacy Management, and as an ASHP delegate for Ohio. He has been an active leader within the Section of Pharmacy Practice Leaders (SPPL), including as chair of the Section Advisory Group for Quality and Compliance and as director-at-large and chair of the SPPL. Calabrese served as faculty for the ASHP Foundation's Pharmacy Leadership Academy and ASHP's Australia Leadership Boot Camp and as a capstone facilitator for ASHP Certified Pharmacy Executive Leaders. He is a past president of the Cleveland Society of Health-System Pharmacists (CSHP) and the Ohio Society of Health-System Pharmacists (OSHP) and has been recognized with CSHP's Evlyn Gray Scott Award and OSHP's Walter M. Frazier Award. He holds a bachelor's degree in pharmacy from the Philadelphia College of Pharmacy and Science, an MBA from Cleveland State University, and a certification in executive coaching from the Gestalt Institute of Cleveland. The ASHP Board of Directors selected Calabrese following a comprehensive national search. The board expressed its sincere gratitude to Douglas Scheckelhoff for serving as interim CEO during the search and CEO transition. About ASHP ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs and provides comprehensive resources to support pharmacy professionals through every stage of their careers. For more information, visit ashp.org and ASHP's consumer website, SafeMedication.com. Learn more about ASHP's public awareness campaign at yourpharmacist.org. Posted March 19, 2026

Samford University
Aug 14th, 2025
Samford Pharmacy Professor Kim Benner Elected Next President of American Society of Health-System Pharmacists

Kim Benner, PharmD '96, professor of pharmacy practice at Samford University's McWhorter School of Pharmacy, has been elected president of the American Society of Health-System Pharmacists (ASHP) which will be effective June 2026.